Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.
Illumina is a leading company in the field of genomics, providing innovative sequencing and array-based solutions for genetic analysis. Their technologies are used by researchers, clinicians, and pharmaceutical companies to understand the genetic basis of diseases, improve patient care, and advance drug discovery.
30000 / day
50000 / day
4.5 pages per visit
Domain Rating
Domain Authority
Citation Level
English, etc
Offers high-throughput sequencing technologies that enable rapid sequencing of DNA and RNA, facilitating a wide range of genomic applications.
Provides array-based solutions for genetic analysis, including genotyping, gene expression, and methylation studies.
Delivers comprehensive software solutions for data analysis, management, and interpretation, supporting the entire workflow from sample to insight.
Supports clinical research and diagnostics with solutions designed for oncology, reproductive health, genetic disease, and more.
Engages in partnerships with academic, government, and industry researchers to advance the understanding of genomics and its applications.
San Diego, California, USA
Operates in over 140 countries with offices and distribution centers worldwide.
Employs more than 7,800 people globally.
Reported revenue of $3.33 billion in 2020.
Francis deSouza (CEO), Jay Flatley (Executive Chairman), and others.
Received numerous awards for innovation, workplace excellence, and contributions to science and healthcare.
Committed to sustainability through responsible business practices, environmental stewardship, and community engagement.
Security headers report is a very important part of user data protection. Learn more about http headers for illumina.com